Dear colleagues,
I’m delighted to share with you Cancer Frontline from The University of Texas MD Anderson Cancer Center.
As our allies in the fight to eliminate cancer, we want you to be in the know about the latest research, discoveries and advances as they happen at MD Anderson. Cancer Frontline will keep you informed of our work, recognize the significant efforts of our partners and, hopefully, inspire new collaborations...
MD Anderson Cancer Center is ranked No. 2 in cancer care by the U.S. News & World Report’s annual “Best Hospitals” survey.
Since...
How can technological innovation help end cancer?
That's the question IBM and MD Anderson Cancer Center recently posed when they teamed...
An MD Anderson researcher has been awarded for his work leading to an entirely new way to treat cancer.
James Allison, Ph.D., chair of Immunology, and Tasuku Honjo, M.D., Ph.D., dean of Kyoto University’s Faculty of Medicine in Japan, recently received the first Tang Prize for Biopharmaceutical Science. The pair were awarded for their research in cancer immunotherapy, a new type of treatment that stimulates the body’s immune system...
Researchers from the MD Anderson Cancer Center found that 93% of head and neck cancer patients treated with multi-field optimization intensity...
Collaborations are crucial to making significant advancements toward ending cancer. Creating a worldwide network of basic, translational,...
MD Anderson Cancer Center is expanding its efforts to combat lung cancer and other diseases. And an important piece of this initiative will...
The following opinion piece includes the collective thoughts of several MD Anderson prevention researchers
Recently, the Food and Drug...
The G.H.A. Clowes Memorial Award is the oldest honor bestowed on a researcher by the American Association for Cancer Research. It's been given...
The promise of immunotherapy, drugs that stimulate the body's immune system to fight cancer, can be witnessed by observing the string of development...